InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Wiley Matthew T., Directeur Commercial. Officer active across 3 companies, notably VYNE Therapeutics Inc.. Cumulatively, 9 filings have been recorded. Split: 0 buy · 1 sell. Activity tracked since 30 June 2021. The latest transaction was filed on 12 August 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Wiley Matthew T.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
62,500 shares0Common SharesSEC:0001193125-26-345836:0
2,867 sharesCommon SharesSEC:0001193125-26-285558:0
62,500 sharesCommon SharesSEC:0001193125-26-276881:0
115,000 shares0Common SharesSEC:0001193125-26-039598:0
21,250 sharesCommon StockSEC:0001104659-24-106064:0
750 sharesCommon StockSEC:0001104659-24-100746:0
750 sharesCommon StockSEC:0001104659-24-073003:0
3,000 sharesCommon StockSEC:0001104659-24-044859:0
5,151 shares@ US$3.51100.0% of flowCommon StockSEC:0001209191-21-044980:0
9 of 9 declarations
About Wiley Matthew T.
Wiley Matthew T. is Chief Commercial Officer. He is linked to Definium Therapeutics, Inc., BioXcel Therapeutics, Inc. and VYNE Therapeutics Inc., and his record includes 9 filings in total. Among the recent filings tracked, the period runs from 2021-07-02 to 2026-08-12, with buy and sell amounts shown as EUR 0, and the modal transaction nature is Attribution.
